Statement: none of the primary trial participants receive anastrazole in any form, however, all secondary trial participants are prescribed anastrazole
Primary_evidence: INTERVENTION 1:    Arm A - Flaxseed & Active Anastrazole   25 mg flaxseed per day and 1 mg anastrozole pill per day   Anastrozole: 1 mg per day   flaxseed: 25 g per day ground INTERVENTION 2:    Arm B - Flaxseed   Flaxseed 25 mg per day and 1 placebo pill per day   flaxseed: 25 g per day ground
Secondary_evidence: INTERVENTION 1:    Phase 1 - Cohort A   Dual treatment with 1 mg anastrozole orally once daily together with AZD0530 175 mg orally once daily, or as specified per protocol, until disease progression for treatment of metastatic breast cancer   Anastrozole AZD0530